The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

Precocious puberty

Effect of Exogenous Growth Hormone on Ocular Findings A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty. Effect of Prevalence of BMI on Efficacy of Herbal Medicines in Girls’ Sexual Precocity The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome) Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls LH Response to GnRH Test in Prepubescent Girls Under 6 Years The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test Follicle-Stimulating Hormone (FSH) and the Onset of Puberty Histrelin Subcutaneous Implant in Children With Central Precocious Puberty Purification of Testis-Stimulating Factor in Precocious Puberty Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty Effects of Triptorelin Pamoate in Children With Precocious Puberty – Follow up Study Overweight and Obesity and Puberty Development Cohort Study The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty Follow-up of Girls With Premature Thelarche and Precocious Puberty Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty Markers of Pubertal Suppression During Therapy for Precocious Puberty Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children